Latest news
Loading news…
Zhejiang Starry Pharmaceutical
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Hangzhou, Zhejiang, China Founded 1997 1001-5000 employees For Profit
Zhejiang Starry Pharmaceutical is a Pharmaceutical Companny.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
2
Monthly Visits
Available in Pro Contacts
0
Ticker
603520
SSE - Shanghai Stock Exchange
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- 603520
- Exchange
- SSE - Shanghai Stock Exchange
- IPO date
- Mar 9, 2016
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Active products
- 2
Investor Activity
- Investments
- 2
- Lead investments
- 1
- Portfolio orgs
- 2
Company Info
- Founded
- 1997
- Employees
- 1001-5000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- HQ
- Hangzhou, Zhejiang, China
- Region
- Asia-Pacific (APAC)
- Exit date
- Mar 9, 2016
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- -3.8
- Trend (90d)
- -4.3
Investments by Zhejiang Starry Pharmaceutical
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Zhejiang Starry Pharmaceutical
Loading news…
FAQs about Zhejiang Starry Pharmaceutical
People who checked this page also checked these
Browse the full Acquirezy directory.